Abstract
Lipid rafts are microdomains of plasma membranes enriched in cholesterol and sphingolipids in the outer layer. We determined whether κ opioid receptors (KOR) in human placenta and FLAG (DYKDDDDK)-tagged human KOR (FLAG-hKOR) expressed in Chinese hamster ovary (CHO) cells are localized in lipid rafts and whether changes in cholesterol contents affect hKOR properties and signaling. Lipid rafts were prepared from placenta membranes and CHO cells expressing FLAG-hKOR using the Na2CO3 method and fractionation through a sucrose density gradient. The majority of the KOR in the placenta and FLAG-hKOR in CHO cells, determined by [3H]diprenorphine binding and/or immunoblotting with an anti-FLAG antibody, was present in low-density fractions, coinciding with high levels of caveolin-1 and cholesterol, markers of lipid rafts, which indicated that the KOR is localized in lipid rafts. Pretreatment with 2% methyl β-cyclodextrin (MCD) reduced cholesterol content by ∼48% and changed the cells from spindle-shaped to spherical. MCD treatment disrupted lipid rafts, shifted caveolin-1 and FLAG-hKOR to higher density fractions, increased the affinity of (–)-(trans)-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]benzeneacetamide (U50,488H) for the hKOR, and greatly increased U50,488H-induced [35S]guanosine 5′-O-(3-thio)triphosphate binding and p42/44 mitogen-activated protein kinase phosphorylation. Cholesterol replenishment reversed all the MCD effects. Caveolin-1 immunoprecipitated with Gαi proteins and MCD treatment reduced caveolin-1 associated with Gαi proteins, which may contribute to the enhanced agonist-induced G protein activation. Caveolin-1 also immunoprecipitated with FLAG-hKOR, but MCD treatment had no effect on the association. Thus, the KOR is located in lipid rafts and its localization in the microdomains greatly affects coupling to G proteins.
Footnotes
-
This work was supported by National Institutes of Health Grants DA04745, DA11263, and DA17302 and in part by the Pennsylvania Department of Health. S.-I.Y. and P.L.-G.C. acknowledge support from the American Heart Association (0255082N) and the American Cancer Society (PRF-38205-AC-7).
-
doi:10.1124/jpet.105.099507.
-
ABBREVIATIONS: GPCR, G protein-coupled receptor; MAP kinase, mitogen-activated protein kinase; FLAG epitope, (DYKDDDDK); hKOR, human κ opioid receptor(s); FLAG-hKOR, FLAG-tagged human κ opioid receptor(s); CHO, Chinese hamster ovary; CHO-sFLAG-hKOR, CHO cells stably transfected with FLAG-hKOR cDNA that has a signal peptide preceding the FLAG-hKOR; GTPγS, guanosine 5′-3-O-(thio)triphosphate; U50,488H, (–)-(trans)-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]benzeneacetamide; MES, 2-morpholinoethanesulfonic acid; MCD, methyl β-cyclodextrin; CH-MCD, MCD-conjugated cholesterol; HRP, horseradish peroxidase; PAGE, polyacrylamide gel electrophoresis.
- Received December 5, 2005.
- Accepted February 23, 2006.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|